25/04/2018
Press release
BioDiscovery

Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, announced the close of a $60 million USD Series B funding round. The financing will accelerate growth of Corvidia’s ongoing clinical programs, expand scientific and market access capabilities and explore new treatment areas. Venrock led the Series B financing and was joined by five additional new investors, including Andera Partners’ biotech franchise, BioDiscovery To read Corvidia Therapeutics’ press relase, click here

 

Contact us


I am a business person
I am an investor
Other
Surname & given name :
Company :
Telephone :
E-mail :
My message is :